Don’t have an account?
New to Moneycontrol - Sign up now
Its easy and FREE!
OR connect with
A Quick View
6th-Dec-2013 16:45Source: BSE
Dr Reddys Labs- Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Dr Reddys Laboratories Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
5th-Dec-2013 15:18Source: BSE
4th-Dec-2013 12:40Source: BSE
31st-Oct-2013 14:31Source: NSE
Dr. Reddy's Laboratories Limited
Dr. Reddy''s Laboratories Limited has submitted to the exchange the standalone financial results for the period ended 30-Sep-2013.
31st-Oct-2013 14:25Source: NSE
Dr. Reddy''s Laboratories Limited has informed the Exchange regarding a press release dated October 31, 2013 titled "Dr. Reddy''s Q2 & H1 FY14 Financial Results".
31st-Oct-2013 13:57Source: BSE
Dr Reddys Labs- Announces Q2 results, Results Press Release & Limited Review Report for the Quarter ended September 30, 2013
News Body Follows......
14th-Oct-2013 12:23Source: BSE
10th-Oct-2013 11:24Source: BSE
4th-Oct-2013 16:11Source: BSE
Dr Reddys Labs- Q2 results on Oct 31, 2013
Dr Reddys Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on October 31, 2013, inter alia, to consider and approve the Unaudited Financial Result...
17th-Sep-2013 12:01Source: NSE
Dr. Reddy's Laboratories Limited has informed the Exchange regarding Press release dated September 17, 2013 titled "Dr. Reddy's announces the approval of Azacitidine for Injection".
Facebook Twitter RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android